<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31438" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Juvenile Xanthogranuloma </title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Collie</surname>
            <given-names>Jacob S.</given-names>
          </name>
          <aff>SAUSHEC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Harper</surname>
            <given-names>Chelsea D.</given-names>
          </name>
          <aff>Campbell University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fillman</surname>
            <given-names>Eric P.</given-names>
          </name>
          <aff>San Antonio Military Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jacob Collie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chelsea Harper declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Eric Fillman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31438.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Juvenile xanthogranuloma (JXG) is a non-Langerhans cell histiocytosis and is fairly common, often affecting infants and young children. Cutaneous lesions usually resolve spontaneously and most patients have an unremarkable course. Ocular JXG can occur and has an increased incidence in those 2 years of age or younger or in those with multiple lesions. Ocular involvement can be associated with many potential complications including blindness. There is an association of JXG with juvenile myelomonocytic leukemia and neurofibromatosis type 1 (NF1).</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the risk factors for xanthogranulomas.</p></list-item><list-item><p>Describe the typical presentation of a patient with a xanthogranuloma.</p></list-item><list-item><p>Review the pathophysiology of xanthogranulomas.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and communication regarding the management of patients with xanthogranulomas.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31438&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31438">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31438.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Juvenile xanthogranuloma (JXG) is a&#x000a0;relatively&#x000a0;common&#x000a0;entity&#x000a0;and is the most common form of non-Langerhans cell histiocytic&#x000a0;disorder of childhood.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref>,&#x000a0;<xref ref-type="bibr" rid="article-31438.r2">[2]</xref> It is estimated that in&#x000a0;75% of cases, lesions appear during the first year of life, with &#x0003e;15-20% of patients having&#x000a0;lesions at birth.&#x000a0;JXG is rare in adults,&#x000a0;with a&#x000a0;peak incidence in the late twenties to thirties. Rarely, reports exist of lesions arising in the elderly.&#x000a0;The majority of adult patients have solitary lesions.<xref ref-type="bibr" rid="article-31438.r3">[3]</xref>&#x000a0;The true incidence, however, may be underestimated, as many lesions, especially those which are solitary and small (up to 90% of all patients), may go unrecognized.&#x000a0;Typically, the clinical presentation consists of solitary or multiple yellow-orange-brown firm papules or&#x000a0;nodules. The most common locations are the face, neck, and upper torso.<xref ref-type="bibr" rid="article-31438.r3">[3]</xref> &#x000a0;Oral lesions are rare and often occur as a yellow nodule on the lateral aspects of the tongue. Oral lesions can also arise on the gingival, buccal mucosa, and midline hard palate and may ulcerate and bleed. Lesions of the oral mucosa may appear verrucous, umbilicated,&#x000a0;pedunculated, or fibroma-like. Cutaneous lesions are usually asymptomatic, and most lesions spontaneously involute over the course of several years. Although occurring rarely, ocular involvement is the most common extracutaneous site involved, followed by the lungs. Ocular JXG is&#x000a0;nearly always unilateral and develops in less than 0.5% of patients. Approximately 40% of patients with ocular JXG, however, have multiple cutaneous lesions at the time of diagnosis. Ocular&#x000a0;disease usually occurs&#x000a0;prior to 2 years of age and commonly affects the iris. Hyphema and glaucoma are serious complications that can result in blindness and necessitate early referral to an ophthalmologist for evaluation and possible treatment. Other bone, visceral and or CNS involvement (e.g. diabetes insipidus) is unusual. Disease-related deaths are rare.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref>&#x000a0;</p>
        <p>As opposed to other xanthomatous diseases, juvenile xanthogranulomas are not associated with metabolic or lipid disorders.<xref ref-type="bibr" rid="article-31438.r3">[3]</xref></p>
      </sec>
      <sec id="article-31438.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>It is presumed that&#x000a0;juvenile xanthogranulomas develop after unknown stimuli (infectious or physical) and provoke a granulomatous histiocytic reaction.<xref ref-type="bibr" rid="article-31438.r3">[3]</xref>&#x000a0;However, the true etiology of juvenile xanthogranuloma is currently&#x000a0;unknown, and conservative management is generally advised.<xref ref-type="bibr" rid="article-31438.r4">[4]</xref> &#x000a0;</p>
        <p>Juvenile xanthogranulomas have been associated with juvenile chronic myelogenous leukemia (JMML).<xref ref-type="bibr" rid="article-31438.r5">[5]</xref>&#x000a0; Juvenile myelomonocytic leukemia (JMML) is also seen in patients with neurofibromatosis (the incidence is between 1:2000 and 1:5000). Rarely, it is seen in patients with both juvenile xanthogranuloma and neurofibromatosis.<xref ref-type="bibr" rid="article-31438.r4">[4]</xref>&#x000a0; However, when this does occur, these children have a 20- to 32-fold increased risk of juvenile myelomonocytic leukemia when compared to patients with neurofibromatosis alone.<xref ref-type="bibr" rid="article-31438.r6">[6]</xref></p>
        <p>Other diseases associated with juvenile xanthogranuloma include&#x000a0;the following: urticaria pigmentosa, insulin-dependent diabetes mellitus, aquagenic pruritis, and even cytomegalovirus (CMV) infection.<xref ref-type="bibr" rid="article-31438.r5">[5]</xref></p>
      </sec>
      <sec id="article-31438.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Juvenile xanthogranulomas are most commonly found in early childhood with &#x0003e;15-20% of patients having&#x000a0;lesions at birth.&#x000a0;It is estimated that in&#x000a0;75% of cases, lesions appear during the first year of life.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref>&#x000a0;Approximately 10% of cases may appear in adulthood and are known as <italic toggle="yes">adult xanthogranulo</italic>ma<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-31438.r1">[1]</xref> &#x000a0;In children, the disease most often affects males; however, in adults, there is no sex prevalence.<xref ref-type="bibr" rid="article-31438.r3">[3]</xref></p>
      </sec>
      <sec id="article-31438.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Juvenile xanthogranulomas occur most commonly in the skin and show a characteristic morphology. The lesions exhibit a well-demarcated, dense invasion of numerous histiocytes within the superficial dermis and blunting of the rete ridges along with scattered lymphocytes, plasma cells and eosinophils.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref>&#x000a0;Of note, the mononuclear cells may show a spindled or elongated appearance.<xref ref-type="bibr" rid="article-31438.r5">[5]</xref>&#x000a0;Foam cells, foreign body giant cells, and Touton giant cells may be seen in the mature stage.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref>&#x000a0;The characteristic multinucleated giant cell (Touton cell) is observed in 85% of juvenile xanthogranulomas, and these&#x000a0;appear <italic toggle="yes">garland-like</italic>.<xref ref-type="bibr" rid="article-31438.r3">[3]</xref><xref ref-type="bibr" rid="article-31438.r1">[1]</xref>&#x000a0;At the late stage of the lesion, fibroblasts are increased, and fibrosis replaces the infiltration.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref></p>
        <p>In ocular involvement, the tumor cells have abundant cytoplasm and show decreased numbers of Touton cells as compared to cutaneous juvenile xanthogranulomas.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref></p>
        <p>Lesions of juvenile xanthogranuloma classically stain with the following markers: CD68 or Ki-M1P and anti F XIIIa, vimentin, and anti-CD4.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref></p>
      </sec>
      <sec id="article-31438.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Juvenile xanthogranuloma generally&#x000a0;occurs in two forms.<xref ref-type="bibr" rid="article-31438.r7">[7]</xref>&#x000a0;The first form is composed of multiple 2 to 5 millimeter dome-shaped papules that take on a pink to reddish brown hue and, subsequently, turn yellow.<xref ref-type="bibr" rid="article-31438.r7">[7]</xref>&#x000a0;The second form is composed of one or more large nodules which measure 1 to 2 centimeters.<xref ref-type="bibr" rid="article-31438.r7">[7]</xref>&#x000a0;Other variants and presentations include giant juvenile xanthogranuloma, atrophic plaque, cutaneous horn, and subcutaneous mass.<xref ref-type="bibr" rid="article-31438.r7">[7]</xref></p>
        <p>Serious complications can arise when systemic juvenile xanthogranulomas develop. Systemic juvenile xanthogranulomas develop in 4% of children, with an overall mortality of 5% to 10%.<xref ref-type="bibr" rid="article-31438.r6">[6]</xref>&#x000a0; Fatalities are usually due to progressive central nervous system (CNS) disease or liver failure.<xref ref-type="bibr" rid="article-31438.r6">[6]</xref>&#x000a0; Extracutaneous juvenile xanthogranulomas most commonly affect the eye, and ocular involvement has been seen in 0.3% to 10% of children with cutaneous juvenile xanthogranulomas.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref>&#x000a0;Most patients with eye lesions are young children (less than 1 year).<xref ref-type="bibr" rid="article-31438.r3">[3]</xref>&#x000a0;The iris is most commonly involved, and complications can arise that lead to&#x000a0;spontaneous intraocular hemorrhages, glaucoma, and even blinding eye disease.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref>&#x000a0;Of importance, spontaneous hyphema with or without increase of intraocular pressure is a common sign of iris juvenile xanthogranuloma.<xref ref-type="bibr" rid="article-31438.r8">[8]</xref></p>
        <p>Other CNS complications include seizures, increased intracranial pressure, diabetes insipidus, and developmental delay.<xref ref-type="bibr" rid="article-31438.r6">[6]</xref>&#x000a0;These extracutaneous lesions may also be seen in the deeper soft tissues, spleen, and lung.<xref ref-type="bibr" rid="article-31438.r6">[6]</xref></p>
      </sec>
      <sec id="article-31438.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Dermoscopy is a noninvasive technique used as an aid in the diagnosis of juvenile xanthogranuloma.&#x000a0;It&#x000a0;shows a characteristic <italic toggle="yes">setting su</italic>n&#x000a0;appearance (red-yellow center and discrete erythematous halo).&#x000a0;Complete removal via surgical excision gives diagnostic confirmation.&#x000a0;<xref ref-type="bibr" rid="article-31438.r2">[2]</xref></p>
      </sec>
      <sec id="article-31438.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Curative skin excisions may be performed in easily accessible sites; however, most lesions in childhood spontaneously involute and require no therapy.<xref ref-type="bibr" rid="article-31438.r6">[6]</xref></p>
        <p>Management of non-cutaneous (internal) lesions poses greater difficulty and may include any combination of surgery, chemotherapy, radiotherapy, and immunosuppression.<xref ref-type="bibr" rid="article-31438.r3">[3]</xref>&#x000a0;In general, chemotherapy and radiotherapy are options for the patient with symptomatic, unresectable, or incompletely resected extracutaneous disease.<xref ref-type="bibr" rid="article-31438.r4">[4]</xref>&#x000a0;</p>
        <p>Patients with concurrent neurofibromatosis type 1 (NF-1) should receive frequent followup with a complete blood count to monitor for juvenile chronic myelogenous leukemia (JMML).<xref ref-type="bibr" rid="article-31438.r6">[6]</xref>&#x000a0;</p>
        <p>Eye exams are recommended for high-risk patients. Topical, intralesional, and subconjunctival corticosteroids may be administered for ocular involvement.&#x000a0;If complications arise (i.e., glaucoma or hyphema), surgery or systemic steroids may be required.&#x000a0;<xref ref-type="bibr" rid="article-31438.r6">[6]</xref></p>
      </sec>
      <sec id="article-31438.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential of juvenile xanthogranuloma includes both benign and malignant entities, depending on the clinical presentation and site of involvement.</p>
        <p>One of the main differential diagnoses of juvenile xanthogranuloma is Langerhans cell histiocytosis (both may exhibit eosinophils). Helpful morphologic features for Langerhans cell histiocytosis (LCH) are grooved vesicular nuclei with a <italic toggle="yes">coffee bean</italic>" appearance.<xref ref-type="bibr" rid="article-31438.r9">[9]</xref>&#x000a0; Additionally,&#x000a0;immunohistochemistry shows that the cells of LCH are positive for CD1a and S-100, whereas the cells of juvenile xanthogranuloma are negative for CD1a and S-100.<xref ref-type="bibr" rid="article-31438.r9">[9]</xref>&#x000a0;Recall that CD1a is a fairly specific marker for Langerhans cell histiocytosis, and this marker is not expressed in non-LCH diseases.<xref ref-type="bibr" rid="article-31438.r1">[1]</xref></p>
        <p>Reticulohistiocytoma (another non-LCH histiocytic disorder) has a histologic appearance similar to juvenile xanthogranuloma.<xref ref-type="bibr" rid="article-31438.r9">[9]</xref>&#x000a0;This lesion demonstrates large mononucleated or multinucleated histiocytes with a lymphocytic infiltrate and dermal fibrosis.<xref ref-type="bibr" rid="article-31438.r9">[9]</xref>&#x000a0; Although positive for CD68, these are negative for vimentin (unlike juvenile xanthogranuloma).<xref ref-type="bibr" rid="article-31438.r9">[9]</xref></p>
        <p>Although juvenile xanthogranulomas may be found in uncommon locations (i.e., vulva), it is important to remember that other entities (such as embryonal rhabdomyosarcoma) may have a similar histologic appearance and should be ruled out.<xref ref-type="bibr" rid="article-31438.r9">[9]</xref>&#x000a0;The morphologic appearance of monomorphic small round cells with a cambium layer and necrosis would help direct to a malignant diagnosis in such cases.<xref ref-type="bibr" rid="article-31438.r9">[9]</xref></p>
        <p>Other considerations for the differential diagnosis include other xanthomatous lesions, mastocytomas, dermatofibromas, and Spitz nevus.<xref ref-type="bibr" rid="article-31438.r4">[4]</xref></p>
      </sec>
      <sec id="article-31438.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of juvenile xanthogranuloma is generally&#x000a0;excellent with most lesions undergoing spontaneous involution over the course of 3-6 years. Lesions which are of cosmetic concern or pose a risk to vital functions can be treated.<xref ref-type="bibr" rid="article-31438.r6">[6]</xref></p>
      </sec>
      <sec id="article-31438.s11" sec-type="Complications">
        <title>Complications</title>
        <p>There are often minimal to no complications of JXG due to its self-limiting nature. Occasionally, lesions are removed for cosmetic concerns. Ocular lesions often require intervention&#x000a0;to avoid potential complications of blindness, glaucoma or hyphema.&#x000a0;</p>
      </sec>
      <sec id="article-31438.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Ophthalmology&#x000a0;</p>
      </sec>
      <sec id="article-31438.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Isolated intracranial lesions of juvenile xanthogranuloma have been shown to carry a more favorable prognosis (as opposed to other examples of systemic disease).&#x000a0;These lesions have been reported to have a BRAF V600E mutation akin to Langerhans cell histiocytosis and Erdheim-Chester disease. However, further study with a larger patient population is necessary to interpret these findings.&#x000a0;<xref ref-type="bibr" rid="article-31438.r10">[10]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-31438.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of solitary lesions of juvenile xanthogranuloma is often straightforward with routine observation. When multiple lesions are present and or there is the involvement of vital structures, management is best&#x000a0;accomplished&#x000a0;with an interprofessional team. While skin lesions can be excised, those occurring in other parts of the body may cause compression or obstruction of vital tissues.&#x000a0;The outcomes for patients with skin-only lesions is&#x000a0;favorable&#x000a0;but those with lesions in the&#x000a0;CNS may suffer from complications of surgery.<xref ref-type="bibr" rid="article-31438.r11">[11]</xref><xref ref-type="bibr" rid="article-31438.r12">[12]</xref><xref ref-type="bibr" rid="article-31438.r13">[13]</xref> (Level V)</p>
      </sec>
      <sec id="article-31438.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31438&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31438">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/juvenile-xanthogranuloma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31438">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31438/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31438">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-31438.s16">
        <fig id="article-31438.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Juvenile Xanthogranuloma Contributed by Jacob Collie, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JXG1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-31438.s17">
        <fig id="article-31438.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Classic multinucleated (Touton) giant cell of juvenile xanthogranuloma (JXG). Contributed by Jacob Collie, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JXG2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-31438.s18">
        <title>References</title>
        <ref id="article-31438.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pantalon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>&#x00218;tef&#x00103;nache</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Danciu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zurac</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chiseli&#x0021b;&#x00103;</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Iris juvenile xanthogranuloma in an infant - spontaneous hyphema and secondary glaucoma.</article-title>
            <source>Rom J Ophthalmol</source>
            <year>2017</year>
            <season>Jul-Sep</season>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>229</fpage>
            <page-range>229-236</page-range>
            <pub-id pub-id-type="pmid">29450403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Tarl&#x000e9;</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Mesquita</surname>
                <given-names>LAF</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopy in the diagnosis of juvenile xanthogranuloma.</article-title>
            <source>An Bras Dermatol</source>
            <year>2018</year>
            <season>Jan-Feb</season>
            <volume>93</volume>
            <issue>1</issue>
            <fpage>138</fpage>
            <page-range>138-140</page-range>
            <pub-id pub-id-type="pmid">29641718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szczerkowska-Dobosz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kozicka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Purzycka-Bohdan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Biernat</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Stawczyk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nowicki</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Juvenile xanthogranuloma: a rare benign histiocytic disorder.</article-title>
            <source>Postepy Dermatol Alergol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>197</fpage>
            <page-range>197-200</page-range>
            <pub-id pub-id-type="pmid">25097495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murphy</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Soeken</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Megison</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Juvenile xanthogranuloma: diverse presentations of noncutaneous disease.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>36</volume>
            <issue>8</issue>
            <fpage>641</fpage>
            <page-range>641-5</page-range>
            <pub-id pub-id-type="pmid">24065046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bostrom</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Kohut</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dehner</surname>
                <given-names>LP</given-names>
              </name>
            </person-group>
            <article-title>Juvenile xanthogranuloma: forms of systemic disease and their clinical implications.</article-title>
            <source>J Pediatr</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-37</page-range>
            <pub-id pub-id-type="pmid">8765620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haroche</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abla</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.</article-title>
            <source>Hematology Am Soc Hematol Educ Program</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>571</fpage>
            <page-range>571-8</page-range>
            <pub-id pub-id-type="pmid">26637774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vignault</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bourgeault</surname>
                <given-names>&#x000c9;</given-names>
              </name>
              <name>
                <surname>Gagn&#x000e9;</surname>
                <given-names>&#x000c9;</given-names>
              </name>
              <name>
                <surname>Bujold</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A Rare Case of Solitary Giant Congenital Juvenile Xanthogranuloma: A Case Report.</article-title>
            <source>J Cutan Med Surg</source>
            <year>2017</year>
            <season>May/Jun</season>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-269</page-range>
            <pub-id pub-id-type="pmid">28300446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Graeff</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kohler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Munier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bruder</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Juvenile xanthogranuloma involving concurrent iris and skin: Clinical, pathological and molecular pathological evaluations.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>9</volume>
            <fpage>10</fpage>
            <page-range>10-13</page-range>
            <pub-id pub-id-type="pmid">29468209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khurana</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Juvenile Xanthogranuloma in Vulva of a 10-Year-Old Child.</article-title>
            <source>J Clin Diagn Res</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>10</volume>
            <issue>11</issue>
            <fpage>ED21</fpage>
            <page-range>ED21-ED22</page-range>
            <pub-id pub-id-type="pmid">28050386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Techavichit</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sosothikul</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chaichana</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Teerapakpinyo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thorner</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Shuangshoti</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma.</article-title>
            <source>Hum Pathol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>69</volume>
            <fpage>118</fpage>
            <page-range>118-122</page-range>
            <pub-id pub-id-type="pmid">28504206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mori</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakamichi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Multiple Juvenile Xanthogranuloma of the Eyelids.</article-title>
            <source>Ocul Oncol Pathol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>73</fpage>
            <page-range>73-78</page-range>
            <pub-id pub-id-type="pmid">30320084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000f6;ck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zelger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schweigmann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brunner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zelger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kropshofer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kiechl-Kohlendorfer</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>The various clinical spectra of juvenile xanthogranuloma: imaging for two case reports and review of the literature.</article-title>
            <source>BMC Pediatr</source>
            <year>2019</year>
            <month>Apr</month>
            <day>24</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>128</fpage>
            <pub-id pub-id-type="pmid">31018833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31438.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shenoy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singhal</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Shinde</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Solitary Intraspinal Juvenile Xanthogranuloma in an Infant.</article-title>
            <source>Asian J Neurosurg</source>
            <year>2018</year>
            <season>Jan-Mar</season>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>172</fpage>
            <page-range>172-175</page-range>
            <pub-id pub-id-type="pmid">29492155</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
